Conference symposium

Ultromics hosted a Science and Technology Theatre at ASE 2024, showcasing the use of AI and their EchoGo^® platform as a diagnostic aid for HFpEF and cardiac amyloidosis, two complex subtypes of heart failure. The session featured presentations by Ross Upton, Ph.D. (Ultromics), Patricia A. Pellikka, M.D. (Mayo Clinic), Akhil Narang, M.D. (Northwestern Medicine), and Jordan Strom, M.D. (Beth Israel Deaconess Medical Center), who discussed clinical use cases of integrating EchoGo® into their clinical practices.